EVOCOR 2.5 MG BOX OF 30

Treatment of stable, moderate to severe chronic heart failure with reduced systolic ventricular function (ejection fraction <= 35%, based on echocardiography) as an adjunct to angiotensin converting enzyme (ACE) inhibitors and diuretics, and possibly digitalis.

Category: Cardio-Metabolic

Description
Reviews (0)

Description

Specialty	EVOCOR 10
Dosage	10 mg
Form	Film-coated tablet
Presentation	B/30
Primary Packaging	Blister
Specification	ALU, PVC, PVDC
INN	BISOPROLOL
VEIC Classification	Essential
Therapeutic Class	CARDIOVASCULAR SYSTEM
Subclass	BETA-BLOCKING AGENTS
Laboratory	PHILADELPHIA PHARMA
Schedule	A
Shelf Life	24 (months)
Generic/Brand	Generic
Marketing Authorization	9353173
Marketing Authorization Date	2017-01-25
Range	Cardio-Metabolic Range